Clinical Trial Update: The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update on RD06-03 CAR-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• RD06-03 CART cell (RD06-03 CAR-T cell)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: B Lymphoblastic Leukemia/Lymphoma | EARLY_Phase 1 | Status: RECRUITING